Target intelligence / Profile preview

U6 small nuclear RNA 213, pseudogene (RNU6-213P)

Target
RNU6-213P
Molecular classification
Pseudogene, Small nuclear RNA-derived pseudogene, Non-coding RNA remnant, Other
01

Overview

U6 small nuclear RNA 213, pseudogene (RNU6-213P), is a **nonfunctional, processed pseudogene** originating from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome and is highly conserved due to its central role in splicing nuclear pre-mRNA[2][3]. The human genome contains hundreds of U6-related pseudogenes (including RNU6-213P), which are the result of retrotransposition events, often mediated by LINE-1 elements[4][1]. These pseudogenes are generally transcriptionally silent and do not produce functional RNA or protein, although their presence reflects historical retrotransposition activity and genome evolution[4][1]. **Additional context:** - The **canonical U6 snRNA** participates directly in the catalysis of splicing reactions, and its structural and evolutionary conservation highlights its critical biological function[2][3]. However, **RNU6-213P** itself lacks coding or catalytic ability and does not serve as a target for drugs or biomarker studies. - U6 snRNA-derived *pseudogenes* are markers of retrotransposon-mediated genomic changes, but they do not have established biological or disease roles[4][1]. **Summary:** RNU6-213P is a nomenclature for one of many U6 small nuclear RNA pseudogenes that are relics of genome evolution, are not protein-coding, and have no direct functional or therapeutic significance.

Other names
RNU6-213PRNU6-1033PU6 small nuclear RNA 1033, pseudogeneRNA, U6 small nuclear 1033, pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on U6 small nuclear RNA 213, pseudogene (RNU6-213P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 213, pseudogene (RNU6-213P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call